Navigation Links
Synergy Pharmaceuticals to Present Scientific Posters at the Upcoming Gastroenterology Society Meetings in the U.S. and Europe
Date:7/31/2012

NEW YORK, July 31, 2012 /PRNewswire/ -- Synergy Pharmaceuticals Inc. (Nasdaq: SGYP), a developer of new drugs to treat gastrointestinal disorders and diseases, announced today that poster presentations on plecanatide that will be given at three separate Gastroenterology society meetings this fall.

Plecanatide is currently being developed for the treatment of patients suffering with chronic constipation (CIC) and irritable bowel syndrome-constipation predominant (IBS-C). Plecanatide is an agonist of the guanylate cyclase-C receptor and is the superior analog of the natriuretic peptide, uroguanylin, the physiologic ligand of GC-C.

The scheduled locations, dates, titles and timing of the presentations are:

JOINT INTERNATIONAL NEUROGASTROENTEROLOGY AND MOTILITY MEETING to be held September 6-8, 2012 in Bologna, Italy

Plecanatide, a Superior Analog of Uroguanylin, as an Oral Drug Candidate for Treatment of Gastrointestinal Functional Disorders and Diseases. (P330) Authored by Andrea Brancale, Gary Jacob and Kunwar Shailubhai. [Poster presentation 8 September 2012]

UNITED EUROPEAN GASTROENTEROLOGY WEEK to be held October 20-24, 2012 in Amsterdam, The Netherlands

Orally Administered Plecanatide, A Guanylate Cyclase-C Agonist, Acts in the Proximal Intestine to Stimulate Fluid Secretion to Normalize Bowel Movement. (P1003) Authored by Stephen Comiskey, John Foss and Kunwar Shailubhai. [Poster presentation date to be announced]

AMERICAN COLLEGE OF GASTROENTEROLOGY ANNUAL MEETING to be held October 19-24, 2012 in Las Vegas, NV

Orally Administered Plecanatide, A Guanylate Cyclase-C Agonist, Acts in the Lumen of the Proximal Intestine to Facilitate Normal Bowel Movement in Mice and Monkeys. (P451) Authored by Stephen Comiskey, John Foss, Gary Jacob, Kunwar Shailubhai. [Poster presentation 21 October 2012]

About Synergy Pharmaceu
'/>"/>

SOURCE Synergy Pharmaceuticals Inc.
Copyright©2012 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4

Related medicine technology :

1. One-Year EVOLVE Trial Clinical Results Confirm Comparable Safety And Effectiveness Data Of The Boston Scientific SYNERGY™ Stent Versus PROMUS Element™ Platinum Chromium Stent
2. Savient Pharmaceuticals to Hold First Quarter 2012 Financial Results Conference Call on Wednesday, May 9, 2012
3. Auxilium Pharmaceuticals to Present at the Deutsche Bank 37th Annual Healthcare Conference
4. Nouveau Life Pharmaceuticals (HRID) Contracts with U.S. Manufacturer to Produce New Female Supplement
5. BioElectronics Survey Indicates a Five-Fold Superior Pain Relief Compared to OTC Pharmaceuticals
6. Icahn Issues Statement Regarding Amylin Pharmaceuticals
7. Almost 50 Percent of the Glaucoma Patient Population Remains Untreated, Signifying a Vast Market for Glaucoma Pharmaceuticals, Finds Frost & Sullivan
8. Omthera Pharmaceuticals Announces Positive Top-Line Results from Phase 3 EVOLVE Study
9. Onyx Pharmaceuticals Announces FDA Advisory Committee to Review Carfilzomib for the Treatment of Patients with Relapsed and Refractory Multiple Myeloma
10. Jazz Pharmaceuticals Announces First Quarter 2012 Financial Results Conference Call On May 8, 2012
11. Inovio Pharmaceuticals Granted U.S. Patent Protection for Synthetic Vaccine for Cervical Dysplasia and Cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/17/2013)... , May 17, 2013  Atossa Genetics, Inc. (NASDAQ: ... that Kyle Guse , Chief Financial Officer ... LLP MicroCap Conference on Thursday, May 30, 2013, in ... Hotel. The Company,s presentation is scheduled to ... a live webcast. To access the webcast, go to ...
(Date:5/17/2013)...  Boston Scientific Corporation (NYSE: BSX ) ... Program May 21-24 in Paris . ... rich and diversified set of data this year at ... global chief medical officer, Boston Scientific.  "The primary endpoint ... NG PROMUS trial, which evaluated our Promus PREMIER ™ ...
(Date:5/16/2013)... May 16, 2013  Nektar Therapeutics, (Nasdaq: NKTR ... Robin , is scheduled to present at the upcoming ... at the Sheraton New York Hotel on Tuesday, ... The presentation will be accessible via a Webcast through a ... the Nektar website: http://www.nektar.com . This Webcast will be ...
Breaking Medicine Technology:Atossa Genetics to Present at the Second Annual Marcum LLP MicroCap Conference 2Atossa Genetics to Present at the Second Annual Marcum LLP MicroCap Conference 3Boston Scientific Schedule of Major Events and Presentations at EuroPCR 2013 2Boston Scientific Schedule of Major Events and Presentations at EuroPCR 2013 3Boston Scientific Schedule of Major Events and Presentations at EuroPCR 2013 4Boston Scientific Schedule of Major Events and Presentations at EuroPCR 2013 5Boston Scientific Schedule of Major Events and Presentations at EuroPCR 2013 6Boston Scientific Schedule of Major Events and Presentations at EuroPCR 2013 7Boston Scientific Schedule of Major Events and Presentations at EuroPCR 2013 8Nektar Therapeutics' President and CEO, Howard W. Robin, To Present at the 2013 UBS Global Healthcare Conference in New York City 2
... Ferret Study to be Part of Data Package ... 2007 /PRNewswire-FirstCall/ -- Novavax,Inc. said today that it ... challenge to ferrets inoculated with its pandemic,influenza vaccine, ... on,schedule later this year. , In the study, ...
... BOSTON--(BUSINESS WIRE)--May 2, 2007 - Acorda Therapeutics, ... Phase 3 clinical trial,of Fampridine-SR in people ... of Neurology meeting. Andrew Goodman, M.D.,Director of ... of,Rochester, presented top-line results on walking ability, ...
Cached Medicine Technology:Novavax Reports Positive Pre-Clinical Study Results from Live Virus,Challenge to Pandemic Flu Vaccine 2Novavax Reports Positive Pre-Clinical Study Results from Live Virus,Challenge to Pandemic Flu Vaccine 3Acorda Therapeutics Presents Data from its Phase 3 Study of,Fampridine-SR in Multiple Sclerosis at the American Academy of,Neurology Meeting 2Acorda Therapeutics Presents Data from its Phase 3 Study of,Fampridine-SR in Multiple Sclerosis at the American Academy of,Neurology Meeting 3Acorda Therapeutics Presents Data from its Phase 3 Study of,Fampridine-SR in Multiple Sclerosis at the American Academy of,Neurology Meeting 4Acorda Therapeutics Presents Data from its Phase 3 Study of,Fampridine-SR in Multiple Sclerosis at the American Academy of,Neurology Meeting 5Acorda Therapeutics Presents Data from its Phase 3 Study of,Fampridine-SR in Multiple Sclerosis at the American Academy of,Neurology Meeting 6Acorda Therapeutics Presents Data from its Phase 3 Study of,Fampridine-SR in Multiple Sclerosis at the American Academy of,Neurology Meeting 7
(Date:5/18/2013)... Vegas, Nevada (PRWEB) May 18, 2013 ... Cambogia Extract weight loss supplement, which features unmatched potency ... , “Creation's Gold was set up to provide the ... as they work to achieve their wellness goals. The ... need to lead happier, healthier lives. We started by ...
(Date:5/17/2013)... 2013. Chronic trauma can inflict lasting damage to brain ... of people with post-traumatic stress disorder, or PTSD, have ... response to stressful tasks, such as recalling a traumatic ... face. Now, researchers at NYU School of Medicine have ... brains of combat veterans with PTSD in the absence ...
(Date:5/17/2013)... May 17, 2013 Daily Gossip announced on ... the creator of the Program Yourself Thin regime, ... their online website by the end of the month in ... to successfully reeducate themselves and lead a healthy lifestyle, free ... Yourself Thin package is available for only $97 and ...
(Date:5/17/2013)... 2013 Johnson & Johnson subsidiary DePuy ... sales of metal-on-metal hip replacements. This comes after the ... amid lawsuits and calls for increased regulation,** and after ... The Rottenstein Law Group LLP, a metal-on-metal hip implant ... from the market and notes that it maintains a ...
(Date:5/17/2013)... A May 13, 2013 report by ... By Getting Surgery” examines the typical motivation of post-divorce ... According to the article these patients typically fit into ... to freshen their look because they’re now back on ... plastic surgery before their divorce but never ...
Breaking Medicine News(10 mins):Health News:Creation's Gold Launches Potent Garcinia Cambogia Supplement for Weight Loss 2Health News:For combat veterans suffering from post-traumatic stress disorder, 'fear circuitry' in the brain never rests 2Health News:Program Yourself Thin Review and Secrets Revealed By Daily Gossip Magazine 2Health News:DePuy Announces It Will Stop Selling Metal-On-Metal Hip Implants, Notes Rottenstein Law Group LLP 2Health News:DePuy Announces It Will Stop Selling Metal-On-Metal Hip Implants, Notes Rottenstein Law Group LLP 3Health News:Plastic Surgery – Is ‘Revenge’ Cosmetic Surgery on the Rise? 2
... and Lausanne, Switzerland, May 8, 2012 Gene Signal, ... angiogenesis based conditions, today announced that positive data from ... nonhuman primate model of choroidal neovascularization has been presented ... Florida. Topical administration of aganirsen was found to inhibit ...
... Bethesda, MD (May 7, 2012) The ... Safety Practice Improvement Module (PIM) has received ... Medicine (ABIM) to be part of ABIM,s ... physicians, gastroenterologists and any internal medicine subspecialists ...
... calculate physicians, fees under Medicare which in turn ... they will pay doctors -- the Centers for Medicare ... an American Medical Association advisory panel. A study led ... of Public Health, found that the Medicare and Medicaid ...
... 7, 2012 Scientists at The Scripps Research Institute have ... cells, the immune cells that make antibodies against infections. The ... can work more efficiently and hints at therapies for conditions ... lupus erythymatosus, severe allergies, and B-cell lymphomas. The discovery ...
... , MONDAY, May 7 (HealthDay News) -- A ... their child,s weight and that could lead to overfeeding, researchers ... percent less likely [than the mothers of normal-weight children] to ... by Erin Hager of the University of Maryland School of ...
... Randy Dotinga HealthDay Reporter , MONDAY, May 7 (HealthDay ... at bay, a new study suggests you can do so by ... that having a purpose will make a difference, and it,s possible ... the study found that people who had more purpose -- as ...
Cached Medicine News:Health News:Gene Signal presents data at ARVO 2012 showing topical aganirsen is active in retinal disease 2Health News:AGA releases first independently developed ABIM-approved Practice Improvement Module in GI 2Health News:AMA committee recommendations on doctor fees set by Medicare are followed 9 times out of 10 2Health News:Scripps Research scientists show how memory B cells stay 'in class' to fight different infections 2Health News:Scripps Research scientists show how memory B cells stay 'in class' to fight different infections 3Health News:In Mom's Eyes, Overweight Toddler May Not Be 2Health News:Having a 'Purpose in Life' May Help Shield You From Dementia 2Health News:Having a 'Purpose in Life' May Help Shield You From Dementia 3
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
Medicine Products: